30203009: Paromomycin sulfate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Antibacterial\Substance with aminoglycoside structure and antibacterial mechanism of action (substance)\Paromomycin sulfate
\Substance categorized by disposition\Antiprotozoal\Paromomycin sulfate
\Substance categorized by disposition\Anthelmintic\Paromomycin sulfate

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\...

\Antibacterial\Substance with aminoglycoside structure and antibacterial mechanism of action (substance)\Paromomycin sulfate

\Antiprotozoal\Paromomycin sulfate

\Anthelmintic\Paromomycin sulfate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Glycoside (substance)\Aminoglycoside (substance)\Substance with aminoglycoside structure and antibacterial mechanism of action (substance)\Paromomycin sulfate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

50544015 Paromomycin sulfate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

484515018 Paromomycin sulphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

761182019 Paromomycin sulfate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2659761000005116 Paromomycinsulfat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Paromomycin sulfate	Is a	Paromomycin	false	Inferred relationship	Some
Paromomycin sulfate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antileishmanial	false	Inferred relationship	Some
Paromomycin sulfate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Amebicide (disposition)	false	Inferred relationship	Some
Paromomycin sulfate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Paromomycin	true	Inferred relationship	Some
Paromomycin sulfate	Is a	Aminoglycoside (substance)	false	Inferred relationship	Some
Paromomycin sulfate	Is a	Antileishmaniamiddel	false	Inferred relationship	Some
Paromomycin sulfate	Is a	Amoebicide	false	Inferred relationship	Some
Paromomycin sulfate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antiprotozoal	true	Inferred relationship	Some
Paromomycin sulfate	Is a	Antiprotozoal	true	Inferred relationship	Some
Paromomycin sulfate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Anthelmintic (disposition)	true	Inferred relationship	Some
Paromomycin sulfate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antibacterial (disposition)	true	Inferred relationship	Some
Paromomycin sulfate	Is a	Substance with aminoglycoside structure and antibacterial mechanism of action (substance)	true	Inferred relationship	Some
Paromomycin sulfate	Is a	Anthelmintic	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paromomycin sulfate	Inferred relationship	Some
Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paromomycin sulfate	Inferred relationship	Some	1
Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Paromomycin sulfate	Inferred relationship	Some	1
Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Paromomycin sulfate	Inferred relationship	Some	1

This concept is not in any reference sets